| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
41,545 |
36,289 |
$1.91M |
| 99213 |
|
22,478 |
19,670 |
$890K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13,622 |
12,048 |
$305K |
| 87633 |
|
847 |
830 |
$243K |
| 99396 |
|
2,131 |
2,065 |
$236K |
| 99395 |
|
1,403 |
1,359 |
$159K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
6,116 |
5,984 |
$115K |
| 93000 |
|
2,992 |
2,921 |
$98K |
| 99394 |
|
1,219 |
1,155 |
$89K |
| 90750 |
|
431 |
430 |
$87K |
| 90688 |
|
3,221 |
3,183 |
$67K |
| 99393 |
|
1,076 |
1,002 |
$61K |
| 92552 |
|
2,554 |
2,525 |
$54K |
| 82947 |
|
17,040 |
14,659 |
$48K |
| 90732 |
|
258 |
258 |
$39K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
990 |
955 |
$29K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,600 |
1,498 |
$27K |
| 90686 |
|
1,043 |
1,038 |
$25K |
| 90662 |
|
372 |
372 |
$24K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,381 |
2,319 |
$23K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
15 |
14 |
$18K |
| 90715 |
|
492 |
485 |
$17K |
| 94060 |
|
310 |
307 |
$15K |
| 96372 |
|
3,174 |
2,941 |
$14K |
| 99173 |
|
3,161 |
3,000 |
$13K |
| 99407 |
|
549 |
513 |
$12K |
| 99406 |
|
895 |
840 |
$12K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,983 |
1,888 |
$12K |
| 99392 |
|
205 |
195 |
$9K |
| 92551 |
|
648 |
633 |
$9K |
| 80305 |
|
760 |
709 |
$7K |
| 81002 |
|
4,180 |
3,965 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,329 |
1,311 |
$7K |
| 0012A |
|
151 |
151 |
$6K |
| 0011A |
|
172 |
172 |
$6K |
| 90658 |
|
216 |
216 |
$5K |
| 99203 |
|
125 |
122 |
$5K |
| 90673 |
|
83 |
83 |
$4K |
| 94640 |
|
295 |
284 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
578 |
563 |
$4K |
| 90651 |
|
328 |
306 |
$4K |
| 11981 |
|
15 |
14 |
$4K |
| 0013A |
|
89 |
89 |
$3K |
| 85018 |
|
2,001 |
1,975 |
$3K |
| 99385 |
|
26 |
26 |
$3K |
| 90670 |
|
44 |
40 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
105 |
101 |
$2K |
| 99386 |
|
13 |
12 |
$2K |
| 90734 |
|
188 |
169 |
$2K |
| 96110 |
|
24 |
24 |
$2K |
| 0001A |
|
39 |
39 |
$2K |
| 87631 |
|
29 |
28 |
$1K |
| 90682 |
|
14 |
14 |
$1K |
| 81025 |
|
442 |
418 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
206 |
199 |
$1K |
| 90620 |
|
51 |
51 |
$1K |
| Z1034 |
|
19 |
12 |
$1K |
| 0002A |
|
21 |
21 |
$840.00 |
| 99391 |
|
13 |
12 |
$531.17 |
| 90648 |
|
45 |
38 |
$477.45 |
| 90630 |
|
16 |
16 |
$476.16 |
| 99442 |
|
40 |
37 |
$470.67 |
| 99401 |
|
926 |
852 |
$299.06 |
| 90700 |
|
28 |
27 |
$293.40 |
| 87070 |
|
26 |
26 |
$195.26 |
| 3078F |
|
5,579 |
5,118 |
$157.41 |
| 90716 |
|
13 |
13 |
$140.40 |
| 90707 |
|
12 |
12 |
$129.60 |
| 3008F |
|
29,460 |
23,992 |
$127.36 |
| 3074F |
|
5,620 |
5,138 |
$99.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19 |
19 |
$91.78 |
| 3077F |
|
10,214 |
8,660 |
$88.35 |
| 3080F |
|
9,349 |
7,836 |
$71.18 |
| 4050F |
|
3,766 |
3,465 |
$52.41 |
| 3075F |
|
1,214 |
1,172 |
$41.56 |
| 3079F |
|
1,932 |
1,806 |
$24.35 |
| 3044F |
|
1,318 |
1,195 |
$9.26 |
| 1123F |
|
8,739 |
7,763 |
$9.26 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
126 |
120 |
$5.62 |
| 4010F |
|
54 |
54 |
$0.00 |
| 1000F |
|
1,156 |
1,130 |
$0.00 |
| 1157F |
|
43 |
37 |
$0.00 |
| 90471 |
|
2,071 |
1,932 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
75 |
74 |
$0.00 |
| 1036F |
|
1,531 |
1,509 |
$0.00 |
| 3014F |
|
77 |
68 |
$0.00 |
| 3052F |
|
13 |
12 |
$0.00 |
| 1111F |
|
267 |
247 |
$0.00 |
| 1034F |
|
39 |
38 |
$0.00 |
| G9691 |
Patient had hospice services any time during the measurement period |
40 |
38 |
$0.00 |
| 3061F |
|
21 |
21 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
243 |
229 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
86 |
83 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
20 |
15 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
209 |
194 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
180 |
171 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
483 |
442 |
$0.00 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
569 |
550 |
$0.00 |
| 3051F |
|
40 |
39 |
$0.00 |
| 90472 |
|
526 |
487 |
$0.00 |
| 3046F |
|
58 |
54 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
167 |
156 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
42 |
41 |
$0.00 |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
136 |
128 |
$0.00 |
| 4040F |
|
13 |
13 |
$0.00 |
| 99072 |
|
74 |
70 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
32 |
31 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
13 |
13 |
$0.00 |